CRONOS GROUP INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
CRONOS GROUP INC. (CRON) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $5.42 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-02-26
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was 23.93 CAD/shares, a 164.42% increase year-over-year.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was 9.05 CAD/shares, a 27.37% decline year-over-year.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was 12.46 CAD/shares, a 15.30% decline year-over-year.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2021-03-31 was 14.71 CAD/shares, a 14.33% decline year-over-year.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2024 was 19.05 CAD/shares, a 145.81% increase from fiscal 2023.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was 7.75 CAD/shares, a 35.02% increase from fiscal 2022.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was 5.74 CAD/shares, a 53.60% decline from fiscal 2021.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was 12.37 CAD/shares, a 13.74% decline from fiscal 2020.
CAD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-09-30 | 14.70 CAD/shares 10-Q · filed 2025-11-06 | |||
| 2024-12-31 | 19.05 CAD/shares 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 19.05 CAD/shares 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 19.05 CAD/shares 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 23.93 CAD/shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 7.75 CAD/shares 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 7.75 CAD/shares 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 7.75 CAD/shares 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | 9.05 CAD/shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 5.74 CAD/shares 10-K · filed 2024-02-29 | |||
| 2022-09-30 | 11.26 CAD/shares 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | 13.56 CAD/shares 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | 12.46 CAD/shares 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | 12.37 CAD/shares 10-K · filed 2023-02-28 | |||
| 2021-09-30 | 10.73 CAD/shares 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | 14.86 CAD/shares 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | 14.71 CAD/shares 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 14.34 CAD/shares 10-K · filed 2022-03-01 | |||
| 2020-09-30 | 15.06 CAD/shares 10-Q · filed 2022-02-18 | |||
| 2020-06-30 | 15.78 CAD/shares 10-Q/A · filed 2022-02-18 | |||
| 2020-03-31 | 17.17 CAD/shares 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | 2.27 CAD/shares 10-K · filed 2021-02-26 | |||
| 2019-09-30 | 0.00 CAD/shares 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | 1.63 CAD/shares 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | 1.40 CAD/shares 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | 2.43 CAD/shares 10-K/A · filed 2020-03-30 | |||
| 2017-12-31 | 1.15 CAD/shares 10-K/A · filed 2020-03-30 |
USD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $5.42 10-K · filed 2026-02-26 |
| 2024-12-31 | $19.05 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |